Clinical Trials · NCT01097044
Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 77
- Start date
- Apr 2010
- Locations
- 6 sites, United States
- Primary endpoint
- Time in Direct Sunlight Between 10:00-15:00 on Pain-free Days